Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.
about
Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS.Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.Vaccine therapy for cytomegalovirus in the setting of allogeneic hematopoietic cell transplantation.Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations.Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission.
P2860
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Comparing i.v. BU dose intensi ...... eukemia Working Party of EBMT.
@en
Comparing i.v. BU dose intensity between two regimens
@nl
type
label
Comparing i.v. BU dose intensi ...... eukemia Working Party of EBMT.
@en
Comparing i.v. BU dose intensity between two regimens
@nl
prefLabel
Comparing i.v. BU dose intensi ...... eukemia Working Party of EBMT.
@en
Comparing i.v. BU dose intensity between two regimens
@nl
P2093
P2860
P356
P1476
Comparing i.v. BU dose intensi ...... eukemia Working Party of EBMT.
@en
P2093
A Bermudez
L Lopez-Corral
M A Kharfan-Dabaja
P2860
P2888
P304
P356
10.1038/BMT.2014.133
P407
P577
2014-06-30T00:00:00Z
P6179
1005594815